18F-fludeoxyglucose (18F-FDG)

DRUG2 trials

Conditions

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaCancerMale Breast CancerMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Adult Brain Tumor

Phase 1

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

CompletedNCT01806675

Sanjiv Sam GambhirAdult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma +41

Start: 2013-03-04End: 2019-04-30Updated: 2019-10-03

Phase 2

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

CompletedNCT00375830

Stanford UniversityCancer

Start: 2006-01-31End: 2019-03-14Updated: 2023-12-12

18F-fludeoxyglucose (18F-FDG)

Sponsors

Conditions

Phase 1

Phase 2